SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-004870
Filing Date
2021-10-13
Accepted
2021-10-13 19:37:35
Documents
1
Period of Report
2021-10-11

Document Format Files

Seq Description Document Type Size
1 form4-10132021_041029.html 4  
1 form4-10132021_041029.xml 4 3120
  Complete submission text file 0001415889-21-004870.txt   4625
Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 5445 DTC PARKWAY, SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address
MACALUSO MICHAEL (Reporting) CIK: 0001096423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 211322245

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations